@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NG0BCVRD-J skos:prefLabel "Silymarine"@fr, "Silymarin"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-S5TSM3FL-F . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZSNM46JS-3 skos:prefLabel "Antinéoplasiques d'origine végétale"@fr, "Antineoplastic Agents, Phytogenic"@en ; a mesh:Descriptor, skos:Concept . jvr:-S5TSM3FL-F skos:hiddenLabel "2,3-Dehydrosilybin"@en, "Silibinin A"@en, "Cefasilymarin"@en, "Ardeyhepan"@en, "Lagosa"@en, "Silybine A"@fr, "Silybin B"@en, "HepaBesch"@en, "Alepa-forte"@en, "Silibinin B"@en, "Silybine B"@fr, "Hepar-Pasc"@en, "Legalon Forte"@en, "Heplant"@en, "Silibinine A"@fr, "Hepa-loges"@en, "Silybin A"@en, "Durasilymarin"@en, "Silibinine B"@fr, "Hepa-Merz Sil"@en, "Heparsyx"@en ; skos:altLabel "Silibinin"@en, "853OHH1429"@fr, "853OHH1429"@en, "4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-"@fr, "4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-"@en, "22888-70-6 (Silybin)"@fr, "22888-70-6 (Silybin)"@en, "4RKY41TBTF"@fr, "4RKY41TBTF"@en, "Silybine"@fr, "Silybinin"@en, "Silibin"@en, "33X338MNE4"@fr, "33X338MNE4"@en ; mesh:allowableQualifier jvr:-W6SQV79N-S, jvr:-G4R176S9-J, jvr:-D0F21513-5, jvr:-FWD2BGQ0-9, jvr:-NB0XHT3S-N, jvr:-S0CS1X5R-5, jvr:-BT300B3G-Q, jvr:-NFTHND7Q-8, jvr:-WK5F724J-1, jvr:-R0ZCQ8X6-J, jvr:-Q3979798-W, jvr:-NHL3D2X0-S, jvr:-THHNVC7V-3, jvr:-XV06LPML-W, jvr:-M63HSDM7-1, jvr:-TJHVZCRZ-0, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-R3QWLHRG-V, jvr:-CB30NGKB-3, jvr:-H7K65Q8S-Z, jvr:-NKM836P1-M, jvr:-T9HQD7ST-J, jvr:-L6C0XPHT-4, jvr:-HQRFT0C6-B ; a skos:Concept, mesh:Descriptor ; dc:established "2019-01-01"^^xsd:date ; dc:modified "2018-05-07"^^xsd:date ; skos:prefLabel "Silybin"@en, "Silibinine"@fr ; owl:sameAs ; skos:broader jvr:-NG0BCVRD-J ; skos:inScheme jvr: ; skos:definition "The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers."@en ; dc:created "2018-07-09"^^xsd:date ; mesh:pharmacologicalAction jvr:-WV4LR3SK-0, jvr:-ZSNM46JS-3 . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-WV4LR3SK-0 skos:prefLabel "Agents protecteurs"@fr, "Protective Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .